EVALUATION OF HOSPITAL MORBIDITY AND MORTALITY DUE TO BREAST AND CERVICAL CANCER IN WOMEN IN BRAZIL BETWEEN 2010 AND 2022
Epidemiology. Breast cancer. Cervical cancer. Health inequalities.
Breast and cervical cancer are a serious public health problem worldwide. Early screening, identification and treatment are generally the most widely used means of reducing morbidity and mortality. In Brazil, difficulties in accessing the public health system lead to diagnoses at more advanced stages of cancer and therefore require more aggressive therapeutic approaches that can result in functional, emotional and social sequelae. This study aims to evaluate hospital morbidity and mortality from breast and uterine cancer in relation to Brazilian regions between 2010 and 2022. This is an ecological time series study carried out from 2010 to 2022 using data on hospital admissions and deaths, both in the public domain and stored in the Ministry of Health's DATASUS. The data was analyzed using the Joinpoint Regression program to obtain linear regression and temporal analysis of the variables. In relation to screening for these diseases, it was observed that mammograms and preventive exams showed similar behavior, with a greater supply of these exams until 2019 and a drop during the pandemic period. The results show that between 2010 and 2022, mammography rates ranged from 36 to 71 exams, while Pap smear rates ranged from 126 to 226 cytopathological exams per 1,000 women. Hospitalizations for breast cancer accounted for 147 hospitalizations per 100,000 women and for cervical cancer peaked in 2019, with 48 hospitalizations for the same population. For both, in the years of the pandemic, between 2020 and 2022, there is a drop in hospitalizations in Brazil and in all its regions. Mapping the spatial and temporal distribution of these neoplasms is directly related to human interventions and contributes to cancer control measures. In addition, an increasing trend was observed in the number of deaths related to breast cancer in the Southeast and South regions, as well as cervical cancer in the North and Northeast regions, probably reflecting poorer living and health conditions, less availability of resources and lower primary care coverage. We believe it is important to rethink the priorities in clinical practice and management of the SUS, considering the work process beyond the discussion of therapeutic improvement strategies, but also including the biopsychosocial aspects of women with breast and uterine cancer in the local context, in order to guarantee equity and comprehensive health care. We conclude that although Brazil has several public policies for screening for these diseases, there is still instability in the supply of these tests, reinforcing the weaknesses of the care network and the changes needed in the organization and quality of the services provided.